Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

Post author:Shahid Ahmad
Post published:January 15, 2020
Post category:Uncategorized

Vasomune Therapeutics is currently attending the 38TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

Vasomune Receives a US $2.8 Million PRMRP Grant from the US Department of Defense to Develop AV-001 for the Treatment of ALI/ARDS of Any Cause, Including COVID-19

Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy

The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS)

About

Vasomune Therapeutics 2020 © All Rights Reserved.